Original language | English (US) |
---|---|
Pages (from-to) | 149-153 |
Number of pages | 5 |
Journal | Nature biotechnology |
Volume | 39 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2021 |
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Applied Microbiology and Biotechnology
- Molecular Medicine
- Biomedical Engineering
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Nature biotechnology, Vol. 39, No. 2, 02.2021, p. 149-153.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Building a high-quality Human Cell Atlas
AU - Human Cell Atlas Standards and Technology Working Group
AU - Rozenblatt-Rosen, Orit
AU - Shin, Jay W.
AU - Rood, Jennifer E.
AU - Hupalowska, Anna
AU - Ardlie, Kristin
AU - Clatworthy, Menna
AU - Carninci, Piero
AU - Enard, Wolfgang
AU - Greenleaf, William
AU - Heyn, Holger
AU - Lein, Edward
AU - Levin, Joshua Z.
AU - Linnarsson, Sten
AU - Lundberg, Emma
AU - Meyer, Kerstin
AU - Navin, Nicholas
AU - Nolan, Garry
AU - Teichmann, Sarah
AU - Voet, Thierry
AU - Zhuang, Xiaowei
AU - Regev, Aviv
AU - Heyn, Holger
N1 - Funding Information: We thank A. K. Shalek for insightful comments on the manuscript. This work has received funding from the Ministerio de Ciencia, Innovación y Universidades of Spain (SAF2017-89109-P; AEI/FEDER, UE). J.W.S. received a research grant for the RIKEN Center for Integrative Medical Sciences from MEXT. This project has been made possible in part by grant number 2018-182827 and HCA-A-1704-01742 from the Chan Zuckerberg Initiative DAF, an advised fund of the Silicon Valley Community Foundation. Work was supported by the Manton Foundation, the Klarman Cell Observatory and HHMI (A.R.). This publication is also supported as part of a project (BCLLATLAS and ESPACE) that has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement No 810287 and 874710). We acknowledge support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme / Generalitat de Catalunya. We also acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, and co-financing by the Spanish Ministry of Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014–2020 Smart Growth Operating Program.
PY - 2021/2
Y1 - 2021/2
UR - http://www.scopus.com/inward/record.url?scp=85099923237&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099923237&partnerID=8YFLogxK
U2 - 10.1038/s41587-020-00812-4
DO - 10.1038/s41587-020-00812-4
M3 - Letter
C2 - 33500565
AN - SCOPUS:85099923237
SN - 1087-0156
VL - 39
SP - 149
EP - 153
JO - Nature biotechnology
JF - Nature biotechnology
IS - 2
ER -